Accession Number: | 0001209191-20-037529 |
Date: | 2020-06-16 |
Issuer: | EMMAUS LIFE SCIENCES, INC. (EMMA) |
Original Submission Date: |
NIIHARA YUTAKA
21250 HAWTHORNE BLVD.
SUITE 800
TORRANCE, CA 90503
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.001 PAR VALUE | 2020-06-16 | P | 1,000 | a | $1.67 | 10,672,193 f2 | direct | ||
COMMON STOCK, $0.001 PAR VALUE | 2020-06-16 | 0 | $0.00 | 92,794 | indirect | f3 | |||
COMMON STOCK, $0.001 PAR VALUE | 2020-06-16 | 0 | $0.00 | 63,000 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the price reported is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $1.65 to $1.67, inclusive. the reporting person undertakes to provide to emmaus life sciences, inc., any security holder of emmaus life sciences, inc., and the staff of the securities and exchange commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). |
f2 | the shares shown include shares owned jointly with soomi niihara, the reporting person's wife. |
f3 | hope international hospice, inc, is a california corporation of which dr. niihara and his wife are the sole shareholders and directors. |